Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Roblin

Showing results (1-10 of 252) with videos related to

Pageof 26
Sort By:
Gastroenterologie Clinique Et Biologique|January 8, 2008
[Duodenal ulcer and helicobacter pylori]Xavier Roblin
Expert Opinion on Biological Therapy|July 21, 2015
Could therapeutic drug monitoring of anti-TNF-α be useful to consider a de-escalation of treatment?Mathurin Flamant, Xavier Roblin
Journal of Crohn'S & Colitis|September 30, 2017
The End of the Dosage of 6-Thioguanine Nucleotides? Not so Sure…Xavier Roblin, Stephane Paul
Journal of Crohn'S & Colitis|October 17, 2023
Adalimumab: A 'Maillon Faible' in the Treatment of Ulcerative Colitis?Xavier Roblin, Stephane Paul
The New England Journal of Medicine|November 16, 2012
Tofacitinib in active ulcerative colitisStéphane Paul, Xavier Roblin
La Revue Du Praticien|February 3, 2015
[Non-invasive follow up of patients with inflammatory bowel diseases]Stephane Nancey, Xavier Roblin
Annals of Translational Medicine|August 11, 2018
DIAMOND study: an additional evidence of the interest of being proactive in IBDXavier Roblin, Mathurin Flamant
The American Journal of Gastroenterology|February 6, 2007
Osteoporosis and inflammatory bowel diseaseXavier Roblin, Bruno Bonaz
Alimentary Pharmacology & Therapeutics|May 27, 2023
Editorial: golimumab dosing intensification effective in ulcerative colitis with no need for therapeutic drug monitoring-author's replyMathurin Fumery, Xavier Roblin
Gastroenterology|July 10, 2020
The Nightmare Monitoring of JAKinhibsStéphane Paul, Xavier Roblin
Pageof 26

Showing results (1-10 of 252) with videos related to

Sort By:
Pageof 26
Gastroenterologie Clinique Et Biologique|January 8, 2008
[Duodenal ulcer and helicobacter pylori]Xavier Roblin
Expert Opinion on Biological Therapy|July 21, 2015
Could therapeutic drug monitoring of anti-TNF-α be useful to consider a de-escalation of treatment?Mathurin Flamant, Xavier Roblin
Journal of Crohn'S & Colitis|September 30, 2017
The End of the Dosage of 6-Thioguanine Nucleotides? Not so Sure…Xavier Roblin, Stephane Paul
Journal of Crohn'S & Colitis|October 17, 2023
Adalimumab: A 'Maillon Faible' in the Treatment of Ulcerative Colitis?Xavier Roblin, Stephane Paul
The New England Journal of Medicine|November 16, 2012
Tofacitinib in active ulcerative colitisStéphane Paul, Xavier Roblin
La Revue Du Praticien|February 3, 2015
[Non-invasive follow up of patients with inflammatory bowel diseases]Stephane Nancey, Xavier Roblin
Annals of Translational Medicine|August 11, 2018
DIAMOND study: an additional evidence of the interest of being proactive in IBDXavier Roblin, Mathurin Flamant
The American Journal of Gastroenterology|February 6, 2007
Osteoporosis and inflammatory bowel diseaseXavier Roblin, Bruno Bonaz
Alimentary Pharmacology & Therapeutics|May 27, 2023
Editorial: golimumab dosing intensification effective in ulcerative colitis with no need for therapeutic drug monitoring-author's replyMathurin Fumery, Xavier Roblin
Gastroenterology|July 10, 2020
The Nightmare Monitoring of JAKinhibsStéphane Paul, Xavier Roblin
Pageof 26